Kidney (Chronic renal failure)

Chronic renal disease.
[12114240] BMJ 325(7355): 85-90 (2002)

Chronic kidney disease: whom to screen and how to treat, part 1: definition, epidemiology, and laboratory testing.
[20065899] South Med J 103(2): 140-6 (2010)

The ABCDEs of CKD: a simple approach to early detection and management.
[18791503] South Med J 101(10): 1001-6 (2008)

Proteinuria and microalbuminuria in adults: significance, evaluation, and treatment.
[15558924] South Med J 97(10): 969-79 (2004)

Pathophysiology of progressive renal failure.
[7939915] South Med J 87(10): 1028-33 (1994)

Discharging patients from the nephrology clinic to primary care--will they get appropriate monitoring of renal function?
[19376793] QJM 102(6): 425-8 (2009)

Role of chronic hypoxia and hypoxia inducible factor in kidney disease.
[18298921] Chin Med J (Engl) 121(3): 257-64 (2008)

Progression of chronic renal failure.
[12824091] Arch Intern Med 163(12): 1417-29 (2003)

Chronic renal insufficiency: a diagnostic and therapeutic approach.
[9738603] Arch Intern Med 158(16): 1743-52 (1998)

Natural history of elevated creatinine levels.
[17279186] Can Fam Physician 52(10): 1264-5 (2006)

Identifying and slowing progressive chronic renal failure.
[11785282] Can Fam Physician 47(-): 2512-8 (2001)

End-stage renal disease. Timely, appropriate treatment is crucial.
[10751988] Can Fam Physician 46(-): 511-2, 522-4 (2000)

Chronic kidney disease and its complications.
[18486718] Prim Care 35(2): 329-44, vii (2008)

Cardiovascular complications of renal disease.
[11559693] Heart 86(4): 459-66 (2001)

Causes and consequences of chronic kidney disease: implications for managed health care.
[17402808] J Manag Care Pharm 13(3 Suppl): S1-9 (2007)

Nutritional assessment and treatment of chronic renal failure.
[7395779] Am J Clin Nutr 33(7): 1586-97 (1980)

Symposium on nutrition in renal disease. Proceedings of the Second International Congress on Nutrition in Renal Disease; June 13--15, 1979, Bologna, Italy.
[6104917] Am J Clin Nutr 33(7): 1342-702 (1980)

Abnormal lipid metabolism and renal disorders.
[9163848] Tohoku J Exp Med 181(3): 321-37 (1997)

Preservation of renal function in chronic renal failure.
[1412442] Tohoku J Exp Med 166(1): 165-83 (1992)

Early angiography in patients with chronic kidney disease: a collaborative systematic review.
[19423566] Clin J Am Soc Nephrol 4(6): 1032-43 (2009)

Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.
[19261819] Clin J Am Soc Nephrol 4(3): 542-51 (2009)

Do we know the correct hemoglobin target for anemic patients with chronic kidney disease?
[17699272] Clin J Am Soc Nephrol 1(4): 678-84 (2006)

Aldosterone antagonism in chronic kidney disease.
[17699271] Clin J Am Soc Nephrol 1(4): 668-77 (2006)

Nitric oxide deficiency in chronic kidney disease.
[17928410] Am J Physiol Renal Physiol 294(1): F1-9 (2008)

Function of the chronically diseased kidney. The adaptive nephron.
[4936137] Circ Res 28(5): Suppl 2:1-13 (1971)

Treating elderly people with diabetes and stages 3 and 4 chronic kidney disease.
[18417749] Clin J Am Soc Nephrol 3(4): 1185-94 (2008)

The unique character of cardiovascular disease in chronic kidney disease and its implications for treatment with lipid-lowering drugs.
[17699494] Clin J Am Soc Nephrol 2(4): 766-85 (2007)

Causes and consequences of increased sympathetic activity in renal disease.
[14981063] Hypertension 43(4): 699-706 (2004)

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.
[14604997] Hypertension 42(5): 1050-65 (2003)

Essential hypertension: a renal disease? A review and update of the evidence.
[8478047] Hypertension 21(3): 380-90 (1993)

Antihypertensive functions of the kidney: Arthur C. Corcoran memorial lecture.
[6995288] Hypertension 2(4): 444-64 (1980)

Timing of onset of CKD-related metabolic complications.
[19005010] J Am Soc Nephrol 20(1): 164-71 (2009)

Staging of chronic kidney disease: time for a course correction.
[18385419] J Am Soc Nephrol 19(5): 844-6 (2008)

Frontiers in nephrology: early atherosclerosis--a view beyond the lumen.
[17928505] J Am Soc Nephrol 18(11): 2836-42 (2007)

Frontiers in nephrology: viewing the kidney through the heart--endothelial dysfunction in chronic kidney disease.
[17928504] J Am Soc Nephrol 18(11): 2833-5 (2007)

Chronic kidney disease and mortality risk: a systematic review.
[16738019] J Am Soc Nephrol 17(7): 2034-47 (2006)

Sympathetic hyperactivity in chronic renal failure: a wake-up call.
[14978154] J Am Soc Nephrol 15(3): 524-37 (2004)

Cardiovascular complications in renal failure.
[1777585] J Am Soc Nephrol 2(6): 1053-62 (1991)

The natural history of myocardial disease in dialysis patients.
[1832984] J Am Soc Nephrol 2(1): 2-12 (1991)

Coronary artery disease in uremia: Etiology, diagnosis, and therapy.
[11737581] Kidney Int 60(6): 2059-78 (2001)

Treatment of children with chronic renal failure.
[7752597] Kidney Int 47(3): 951-61 (1995)

Chronic kidney disease: effects on the cardiovascular system.
[17606856] Circulation 116(1): 85-97 (2007)

Diagnosis and management of chronic kidney disease.
[18775206] Mayo Clin Proc 83(9): 1064-9 (2008)

Late referral of patients with chronic kidney disease: no time to waste.
[17120405] Mayo Clin Proc 81(11): 1487-94 (2006)

Early referral for chronic kidney disease: good for those who need it, but who are they?
[17120394] Mayo Clin Proc 81(11): 1420-2 (2006)

National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification.
[12777562] Pediatrics 111(6 Pt 1): 1416-21 (2003)

Guidelines for the management of chronic kidney disease.
[19015566] CMAJ 179(11): 1154-62 (2008)

Progress and promise in the management of chronic kidney disease.
[19015553] CMAJ 179(11): 1107-8 (2008)

Nephrology: 3. Safe drug prescribing for patients with renal insufficiency.
[11873927] CMAJ 166(4): 473-7 (2002)

Musculoskeletal manifestations of chronic renal insufficiency.
[8460225] Radiographics 13(2): 357-79 (1993)

The role of statins in chronic kidney disease.
[21791915] Am J Nephrol 34(3): 195-202 (2011)

Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease.
[20484892] Am J Nephrol 31(6): 541-50 (2010)

The use of targeted biomarkers for chronic kidney disease.
[21044769] Adv Chronic Kidney Dis 17(6): 469-79 (2010)

Mass spectrometry in chronic kidney disease research.
[21044768] Adv Chronic Kidney Dis 17(6): 455-68 (2010)

Progression from acute kidney injury to chronic kidney disease: a pediatric perspective.
[18565478] Adv Chronic Kidney Dis 15(3): 278-83 (2008)

Review of muscle wasting associated with chronic kidney disease.
[20181807] Am J Clin Nutr 91(4): 1128S-1132S (2010)

Survival advantages of obesity in dialysis patients.
[15755821] Am J Clin Nutr 81(3): 543-54 (2005)

The role of hyperuricemia and gout in kidney and cardiovascular disease.
[18822470] Cleve Clin J Med 75 Suppl 5(-): S13-6 (2008)

Vitamin D deficiency in children with chronic kidney disease: uncovering an epidemic.
[19255004] Pediatrics 123(3): 791-6 (2009)

Effects of statins on renal function.
[17976359] Mayo Clin Proc 82(11): 1381-90 (2007)

New insights into diuretic use in patients with chronic renal disease.
[11856788] J Am Soc Nephrol 13(3): 798-805 (2002)

Role of the microvascular endothelium in progressive renal disease.
[11856789] J Am Soc Nephrol 13(3): 806-16 (2002)

Prevention of the development and progression of renal disease.
[12819320] J Am Soc Nephrol 14(7 Suppl 2): S144-7 (2003)

The case for using albuminuria in staging chronic kidney disease.
[19255126] J Am Soc Nephrol 20(3): 465-8 (2009)

Lipoprotein metabolism and lipid management in chronic kidney disease.
[17360943] J Am Soc Nephrol 18(4): 1246-61 (2007)

More on renal disease progression: is interstitial inflammation truly protective?
[17513321] J Am Soc Nephrol 18(6): 1630-2 (2007)

Sympathetic activation in chronic renal failure.
[18799718] J Am Soc Nephrol 20(5): 933-9 (2009)

Metabolic acidosis and progression of chronic kidney disease.
[19696222] J Am Soc Nephrol 20(9): 1869-70 (2009)

Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering?
[16490741] Nephrol Dial Transplant 21(5): 1161-6 (2006)

Are peroxisome proliferator-activated receptors new therapeutic targets in diabetic and non-diabetic nephropathies?
[16880183] Nephrol Dial Transplant 21(10): 2696-702 (2006)

Sympathetic hyperactivity in chronic kidney disease.
[15069180] Nephrol Dial Transplant 19(6): 1354-7 (2004)

Progress with the European Society for Paediatric Nephrology (ESPN)/ERA-EDTA Registry for children with established renal failure (ERF).
[19561347] Nephrol Dial Transplant 24(9): 2615-7 (2009)

Consequences and therapy of the metabolic acidosis of chronic kidney disease.
[20526632] Pediatr Nephrol 26(1): 19-28 (2011)

Heat shock proteins in chronic kidney disease.
[21193931] Pediatr Nephrol 26(7): 1031-7 (2011)

Therapeutic strategies to slow chronic kidney disease progression.
[18335252] Pediatr Nephrol 23(5): 705-16 (2008)

Hypertension in children with chronic kidney disease: pathophysiology and management.
[17990006] Pediatr Nephrol 23(3): 363-71 (2008)

End-stage renal disease: in vivo diffusion-tensor imaging of silent white matter damage.
[19528357] Radiology 252(2): 518-25 (2009)

Molecular mechanisms and therapeutic strategies of chronic renal injury: physiological role of angiotensin II-induced oxidative stress in renal medulla.
[16404134] J Pharmacol Sci 100(1): 2-8 (2006)

Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effects of aldosterone blockade.
[16397374] J Pharmacol Sci 100(1): 9-16 (2006)

Possible underlying mechanisms responsible for aldosterone and mineralocorticoid receptor-dependent renal injury.
[19057124] J Pharmacol Sci 108(4): 399-405 (2008)

Drug discovery for overcoming chronic kidney disease (CKD): pharmacological effects of mineralocorticoid-receptor blockers.
[19151533] J Pharmacol Sci 109(1): 1-6 (2009)

Drug discovery for overcoming chronic kidney disease (CKD): the endothelin ET B receptor/nitric oxide system functions as a protective factor in CKD.
[19151534] J Pharmacol Sci 109(1): 7-13 (2009)

Drug discovery for overcoming chronic kidney disease (CKD): development of drugs on endothelial cell protection for overcoming CKD.
[19151535] J Pharmacol Sci 109(1): 14-9 (2009)

Drug discovery for overcoming chronic kidney disease (CKD): new therapy for CKD by a (pro)renin-receptor-blocking decoy peptide.
[19151536] J Pharmacol Sci 109(1): 20-3 (2009)

Drug discovery for overcoming chronic kidney disease (CKD): prolyl-hydroxylase inhibitors to activate hypoxia-inducible factor (HIF) as a novel therapeutic approach in CKD.
[19151537] J Pharmacol Sci 109(1): 24-31 (2009)

Implantable cardioverter defibrillator therapy in chronic kidney disease: a meta-analysis.
[19812050] Europace 11(11): 1469-75 (2009)

Estimated glomerular filtration rate and the risk of major vascular events and all-cause mortality: a meta-analysis.
[22039429] PLoS One 6(10): e25920 (2011)

Nephrology: 4. Strategies for the care of adults with chronic kidney disease.
[12796336] CMAJ 168(12): 1553-60 (2003)

Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
[20441712] Health Technol Assess 14(21): 1-184 (2010)

Treatment of hypertension in patients with nondiabetic chronic kidney disease.
[17534470] Can J Cardiol 23(7): 595-601 (2007)

Hypertension in dialysis and kidney transplant patients.
[19417862] Can J Cardiol 25(5): 309-14 (2009)

Current status of the measurement of blood hepcidin levels in chronic kidney disease.
[20724518] Clin J Am Soc Nephrol 5(9): 1681-9 (2010)

Survival benefits with vitamin D receptor activation: new insights since 2003.
[20507950] Clin J Am Soc Nephrol 5(9): 1704-9 (2010)

Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results.
[18945995] Clin J Am Soc Nephrol 3(6): 1718-25 (2008)

Improving global outcomes in mineral and bone disorders.
[18988697] Clin J Am Soc Nephrol 3 Suppl 3(-): S127-30 (2008)

Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?
[18184879] Clin J Am Soc Nephrol 3(2): 505-21 (2008)

Guidelines for initiation of renal replacement therapy: dialysis versus transplantation.
[18209422] Saudi J Kidney Dis Transpl 13(3): 257-65 (2002)

Treatment of chronic periodontitis decreases serum prohepcidin levels in patients with chronic kidney disease.
[21655762] Clinics (Sao Paulo) 66(4): 657-62 (2011)

Genomic damage in endstage renal disease-contribution of uremic toxins.
[22069557] Toxins (Basel) 2(10): 2340-58 (2010)

Can we prolong life of patients with advanced chronic kidney disease: what is the clinical evidence?
[21430610] Pol Arch Med Wewn 121(3): 88-93 (2011)

Dyslipidemia in chronic kidney disease: pathogenesis and intervention.
[19776689] Pol Arch Med Wewn 119(7-8): 487-92 (2009)

Scope and mechanisms of obesity-related renal disease.
[20134323] Curr Opin Nephrol Hypertens 19(3): 227-34 (2010)

Mechanisms for increased cardiovascular disease in chronic kidney dysfunction.
[19374004] Curr Opin Nephrol Hypertens 18(3): 181-8 (2009)

Incidence, management, and outcomes of end-stage renal disease in the elderly.
[19374012] Curr Opin Nephrol Hypertens 18(3): 252-7 (2009)

Uric acid: a novel mediator and marker of risk in chronic kidney disease?
[19654543] Curr Opin Nephrol Hypertens 18(6): 526-30 (2009)

Chronic kidney disease in primary care: an opportunity for generalists.
[21359580] J Gen Intern Med 26(4): 356-8 (2011)

Managing dyslipidemia in chronic kidney disease.
[15482558] J Gen Intern Med 19(10): 1045-52 (2004)

National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.
[12859163] Ann Intern Med 139(2): 137-47 (2003)

Screening for chronic kidney disease: which strategy?
[20155721] J Nephrol 23(2): 147-55 (2010)

Sympathetic hyperactivity--a hidden enemy in chronic kidney disease patients.
[17556322] Perit Dial Int 27 Suppl 2(-): S293-7 (2007)

Immune dysfunction in dialysis patients--prevention and treatment strategies.
[18552249] Perit Dial Int 28 Suppl 3(-): S161-6 (2008)

Magnesium in chronic kidney disease: challenges and opportunities.
[20090315] Blood Purif 29(3): 280-92 (2010)

Why do dialysis patients develop a heart of stone and bone of china?
[15809503] Blood Purif 23(3): 203-10 (2005)

Overview of chronic kidney disease in children.
[20299869] Curr Opin Pediatr 22(2): 158-60 (2010)

Alterations of lipid metabolism in chronic nephropathies: mechanisms, diagnosis and treatment.
[20357496] Kidney Blood Press Res 33(2): 100-10 (2010)

Dyslipidemia associated with chronic kidney disease.
[21643500] Open Cardiovasc Med J 5(-): 41-8 (2011)

Causes of dysregulation of lipid metabolism in chronic renal failure.
[20017835] Semin Dial 22(6): 644-51 (2009)

Muscle atrophy in chronic kidney disease results from abnormalities in insulin signaling.
[20797566] J Ren Nutr 20(5 Suppl): S24-8 (2010)

Review article: endothelial progenitor cells in renal disease.
[19444962] Nephrology (Carlton) 14(3): 291-7 (2009)

The growth hormone-insulin-like growth factor-I axis in chronic kidney disease.
[17826224] Growth Horm IGF Res 18(1): 17-25 (2008)

Coronary calcification in patients with end-stage renal disease: a novel endocrine disorder?
[17704043] Hormones (Athens) 6(2): 120-31 (2007)

Controversies in chronic kidney disease staging.
[21611077] Clin Biochem Rev 32(2): 55-9 (2011)

Serum phosphate and mortality in patients with chronic kidney disease.
[20688884] Clin J Am Soc Nephrol 5(12): 2251-7 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Kidney (Chronic renal failure).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Kidney (Chronic renal failure).php on line 92